actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
actemra
boehringer ingelheim indonesia - indonesia - tocilizumab - infus - 20 mg/ml
xolair
novartis indonesia - indonesia - omalizumab - serbuk injeksi - 150 mg
xolair
novartis indonesia - indonesia - omalizumab - serbuk injeksi - 150 mg
patizra
novartis indonesia - indonesia - ranibizumab - cairan injeksi - 10 mg/ml
patizra
novartis indonesia - indonesia - ranibizumab - cairan injeksi - 10 mg/ml
hemlibra
boehringer ingelheim indonesia - indonesia - emicizumab - cairan injeksi - 30 mg/ml
patizra
novartis indonesia - indonesia - ranibizumab - injeksi - 10 mg
patizra
novartis indonesia - indonesia - ranibizumab - injeksi - 10 mg
patizra
novartis indonesia - indonesia - ranibizumab - injeksi - 10 mg